Wu Ling-xi
2015
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
Clinical Journal of Medical Officers
Abstract
Objective To explore the efficacy and safety of compound azintamide enteric-coated tablets in the treatment of patients with biliary dyspepsia.Methods A total of 135 patients with biliary dyspepsia,who visited our hospital from Feburary 2013 to Feburary 2015,were divided into Treatment Group and Control Group under double-blind condition according random number table.Patients in Treatment Group were treated with compound azintamide enteric-coated tablets and conventional therapy.Cases in Control Group were treated with only conventional therapy.Results Before treatment,the general clinical data,the dyspeptic symptoms integral and total integral of the Treatment group were significantly different compared with Control Group( P 0.05).After 2 and 4 weeks of treatment,the dyspeptic symptoms integral of the Treatment group and total integral were decreased obviously compared with Control Group( P 0.01).The clinical efficacy of dyspepsia symptoms were significantly better than Control Group( P 0.01).There was no significant difference of adverse events between the two groups during treatment( P 0.05).Conclusion Compound azintamide entericcoated tablets can effectively improve the dyspeptic symptoms of patients with biliary dyspepsia,and the safety is good.